Harvey Partners LLC Sells 422,000 Shares of Rentokil Initial PLC $RTO

Harvey Partners LLC trimmed its holdings in Rentokil Initial PLC (NYSE:RTO) by 25.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,220,000 shares of the company’s stock after selling 422,000 shares during the period. Rentokil Initial makes up 2.9% of Harvey Partners LLC’s investment portfolio, making the stock its 13th biggest holding. Harvey Partners LLC’s holdings in Rentokil Initial were worth $29,280,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. IFP Advisors Inc increased its position in shares of Rentokil Initial by 115.5% in the second quarter. IFP Advisors Inc now owns 1,282 shares of the company’s stock worth $31,000 after purchasing an additional 687 shares during the last quarter. Sit Investment Associates Inc. increased its holdings in shares of Rentokil Initial by 3.7% in the 1st quarter. Sit Investment Associates Inc. now owns 22,065 shares of the company’s stock worth $505,000 after buying an additional 787 shares during the last quarter. Keystone Financial Services raised its position in shares of Rentokil Initial by 7.9% during the 2nd quarter. Keystone Financial Services now owns 12,292 shares of the company’s stock valued at $295,000 after buying an additional 900 shares in the last quarter. Parallel Advisors LLC raised its position in shares of Rentokil Initial by 416.9% during the 2nd quarter. Parallel Advisors LLC now owns 1,132 shares of the company’s stock valued at $27,000 after buying an additional 913 shares in the last quarter. Finally, Cape Investment Advisory Inc. lifted its holdings in shares of Rentokil Initial by 67.4% during the 1st quarter. Cape Investment Advisory Inc. now owns 2,519 shares of the company’s stock worth $58,000 after acquiring an additional 1,014 shares during the last quarter. Institutional investors own 9.91% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Rentokil Initial in a research note on Friday, November 21st. Zacks Research raised Rentokil Initial from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Berenberg Bank upgraded Rentokil Initial to a “strong sell” rating in a research report on Monday, September 29th. Jefferies Financial Group upgraded shares of Rentokil Initial to a “strong-buy” rating in a research report on Wednesday, October 8th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Rentokil Initial in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Rentokil Initial Stock Performance

Shares of NYSE:RTO opened at $28.67 on Friday. The stock’s 50-day moving average is $27.45 and its 200 day moving average is $25.36. Rentokil Initial PLC has a 1 year low of $19.60 and a 1 year high of $30.10.

Rentokil Initial Profile

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.